tiprankstipranks
Trending News
More News >
Advantis (ADVT)
:ADVT
US Market

Advantis (ADVT) Price & Analysis

Compare
33 Followers

ADVT Stock Chart & Stats


ADVT FAQ

What was Advantis’s price range in the past 12 months?
Currently, no data Available
What is Advantis’s market cap?
Advantis’s market cap is $978.00.
    When is Advantis’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Advantis’s earnings last quarter?
    Currently, no data Available
    Is Advantis overvalued?
    According to Wall Street analysts Advantis’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Advantis pay dividends?
      Advantis does not currently pay dividends.
      What is Advantis’s EPS estimate?
      Advantis’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Advantis have?
      Advantis has 978,465,900 shares outstanding.
        What happened to Advantis’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Advantis?
        Currently, no hedge funds are holding shares in ADVT

        Company Description

        Advantis

        Advantis Corp. develops and markets products focusing on medical cannabis, research, and pharmaceutical sectors. The company offers pain management and healthcare solutions. Advantis Corp. was formerly known as Ramoil Management, Ltd. and changed its name to Advantis Corp. in December 2015. Advantis Corp. is based in Newport Beach, California.
        Similar Stocks
        Company
        Price & Change
        Follow
        Organogenesis Holdings
        cbdMD
        Cosmos Holdings
        Flora Growth
        Akanda Corp
        Popular Stocks
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis